Literature DB >> 1478067

Heparin-binding properties of lactoferrin and lysozyme.

S Zou1, C E Magura, W L Hurley.   

Abstract

1. Binding of biotin-heparin to immobilized lactoferrin and lysozyme was optimum at pH 6.0, 100 mM NaCl. Complex interactions between NaCl and CaCl2 concentrations were observed for heparin binding to both proteins. 2. The metal ions Cu2+, Zn2+, Fe2+ and Fe3+ inhibited heparin binding, with half-maximal inhibition of binding to lactoferrin occurring between 600 microM and 1 mM and for lysozyme between 500 and 800 microM. 3. Binding of biotin-heparin to both proteins was inhibited to varying degrees by heparin, heparan sulfate, chondroitin sulfate A, dextran sulfate and DNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478067     DOI: 10.1016/0305-0491(92)90210-i

Source DB:  PubMed          Journal:  Comp Biochem Physiol B        ISSN: 0305-0491


  12 in total

1.  Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins.

Authors:  G Xu; G G Forstner; J F Forstner
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

2.  N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.

Authors:  P H van Berkel; M E Geerts; H A van Veen; M Mericskay; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

3.  Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.

Authors:  G Pejler
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

4.  Differential effects of murine and human factor X on adenovirus transduction via cell-surface heparan sulfate.

Authors:  Anne K Zaiss; Roger Lawrence; David Elashoff; Jeffrey D Esko; Harvey R Herschman
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

5.  Role of glycosaminoglycans in infectious disease.

Authors:  Akiko Jinno; Pyong Woo Park
Journal:  Methods Mol Biol       Date:  2015

6.  A crosslinked dextran sulfate-chitosan nanoparticle for delivery of therapeutic heparin-binding proteins.

Authors:  Victoria A Guarino; Adam Blau; Jack Alvarenga; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Int J Pharm       Date:  2021-11-11       Impact factor: 5.875

7.  In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate.

Authors:  Robert G Thorne; Aparna Lakkaraju; Enrique Rodriguez-Boulan; Charles Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-09       Impact factor: 11.205

8.  'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.

Authors:  A D Dwarakanath; L G Yu; C Brookes; D Pryce; J M Rhodes
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

9.  Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes.

Authors:  P Sinnis; T E Willnow; M R Briones; J Herz; V Nussenzweig
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate.

Authors:  Agostina Pietrantoni; Claudia Fortuna; Maria Elena Remoli; Maria Grazia Ciufolini; Fabiana Superti
Journal:  Viruses       Date:  2015-01-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.